Nonalcoholic fatty liver disease – an etiological approach

Nonalcoholic fatty liver disease – an etiological approach

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of fat in the liver (hepatic steatosis) either on imaging or on liver histology only after the exclusion of secondary causes of fat accumulation in the liver (e.g. high alcohol drinking, drugs and other medical ailments). Conside...

Full description

Bibliographic Details
Main Authors:	Florentina Ioniță Radu, Mariana Jinga, Petruț Nuță, Raluca S. Costache, Săndica Bucurică, Bogdan Macadon, Vasile Balaban, Mihăiță Pătrășescu
Format:	Article
Language:	English
Published:	Carol Davila University of Medicine and Pharmacy Publishing House 2014-06-01
Series:	Romanian Journal of Military Medicine
Online Access:	http://revistamedicinamilitara.ro/wp-content/uploads/2016/04/2014-12-full.35-41.pdf

Similar Items

Diabetes mellitus and colorectal cancer – a revealed connection
by: Mihăiță Pătrășescu, et al.
Published: (2015-08-01)

Culprits in non-celiac gluten-sensitivity
by: Vasile D. Balaban, et al.
Published: (2015-08-01)

From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
by: Cătălina Diaconu, et al.
Published: (2015-08-01)

Case report – hepatocytolytic syndrome hiding mesenteric venous ischemia
by: Andrada Popescu, et al.
Published: (2015-08-01)

Endoscopic faces of Helicobacter Pylori infection
by: Geanina Spulber, et al.
Published: (2015-08-01)

A cholestatic syndrome may be a surprising cause of medical error
by: M. Pătrășescu, et al.
Published: (2015-04-01)

Ferritin and Ferritin-to-Hemoglobin Ratio as Promising Prognostic Biomarkers of Severity in Acute Pancreatitis—A Cohort Study
by: Mihaela Cristina Pavalean, et al.
Published: (2024-01-01)

Golgi Apparatus Target Proteins in Gastroenterological Cancers: A Comprehensive Review of GOLPH3 and GOLGA Proteins
by: Sandica Bucurica, et al.
Published: (2023-07-01)

Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions—Review of the Literature
by: Sandica Bucurica, et al.
Published: (2022-12-01)

Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet—A Comprehensive Review
by: Daniel Octavian Costache, et al.
Published: (2024-02-01)

Association of Vitamin D Deficiency and Insufficiency with Pathology in Hospitalized Patients
by: Sandica Bucurica, et al.
Published: (2023-03-01)

Acute Esophageal Necrosis in Acute Pancreatitis—Report of a Case and Endoscopic and Clinical Perspective
by: Monica Grigore, et al.
Published: (2023-02-01)

Hematologic Manifestations in Celiac Disease—A Practical Review
by: Daniel Vasile Balaban, et al.
Published: (2019-07-01)

Impact of laparoscopic sleeve gastrectomy on esophageal physiology
by: Popescu Andrada-Loredana, et al.
Published: (2021-09-01)

Estrobolome and Hepatocellular Adenomas—Connecting the Dots of the Gut Microbial β-Glucuronidase Pathway as a Metabolic Link
by: Sandica Bucurica, et al.
Published: (2023-11-01)

Glycemic Abnormalities in Pancreatic Cystic Lesions—A Single-Center Retrospective Analysis
by: Daniel Vasile Balaban, et al.
Published: (2023-05-01)

Oral Anticoagulation in Patients with Chronic Liver Disease
by: Raluca S. Costache, et al.
Published: (2023-02-01)

Hepatocellular carcinoma – A review
by: Gaudia V. Mănescu-Avram, et al.
Published: (2017-04-01)

Prevalence of Coagulopathy in Patients with Celiac Disease: A Single-Center Retrospective Case-Control Study
by: Daniel Vasile Balaban, et al.
Published: (2023-10-01)

Non-alcoholic fatty pancreas disease – practices for clinicians
by: Pinte Larisa, et al.
Published: (2019-09-01)

Upper Gastrointestinal Tract Associated Lesions in Patients with Newly Diagnosed Celiac Disease
by: Iulia Enache, et al.
Published: (2022-02-01)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
by: Otilia Frasinariu, et al.
Published: (2022-05-01)

Cutaneous Manifestations in Pancreatic Diseases—A Review
by: Raluca Miulescu, et al.
Published: (2020-08-01)

Metastatic Renal Cell Carcinoma to Pancreas: Case Series and Review of the Literature
by: Daniel Vasile Balaban, et al.
Published: (2023-04-01)

Role of oxidative stress, gut microbiota and derived metabolites in the etiology and progression of nonalcoholic fatty liver disease
by: Ankita Das, et al.
Published: (2023-10-01)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2023-10-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023-01-01)

History of Nonalcoholic Fatty Liver Disease
by: Amedeo Lonardo, et al.
Published: (2020-08-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

Leptin in nonalcoholic fatty liver disease
by: Billur Canbakan, et al.
Published: (2008-07-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Waseem Amjad, et al.
Published: (2023-08-01)

Effect of a New Synergistic Combination of Low Doses of Acetylsalicylic Acid, Caffeine, Acetaminophen, and Chlorpheniramine in Acute Low Back Pain
by: Victor A. Voicu, et al.
Published: (2019-06-01)

Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Young-Su Yi
Published: (2024-03-01)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01)